Biotechnology & Drugs news, Biotechnology & Drugs industry, industry News

▮ More

FDA Approves Inrebic For Rare Bone Marrow Disorder Treatment

Securities Lawsuit Filed In Denmark Against Novo Nordisk

Can NovoCure Hit $100?

Pfizer Recalls Migraine Tablets Over Concerns Of Bacterial Infection

5 Top Losers In Healthcare Sector (JAGX, HROW, IVC…)

Roche Reports FDA Approval Of Rozlytrek - Quick Facts

Roche: FDA Approved Rozlytrek For Adults With ROS1-positive, Metastatic NSCLC

6 Top Gainers In Healthcare Sector (RMED, BCEL, TROV…)

EARNINGS SUMMARY: Details of Accuray Incorporated Q4 Earnings Report

FDA Approves New Drug For Hard-to-Treat TB

Doctors May Screen Adult Patients For Illicit Drug Use

Orchard Therapeutics Waiting To Bloom

EARNINGS SUMMARY: Details of China Pharma Holdings Inc. Q2 Earnings Report

This Day That Year: Aridis Pharma

Agilent Technologies Q3 adjusted earnings Beat Estimates

INMD In Steady Mode, PSNL Sees Rosy Outlook, QTRX On Watch

AstraZeneca Reports Breakthrough Therapy Designation For Calquence - Quick Facts

AstraZeneca: FDA Grants Breakthrough Therapy Designation For Calquence

AstraZeneca Says Lynparza Phase III PAOLA-1 Trial Meets Primary Endpoint

5 Top Losers In Healthcare Sector (RMED, NMRD, NTRP…)

Evotec H1 Net Result Down, Adj. EBITDA Climbs; Lifts FY19 Outlook - Quick Facts

Evotec H1 Group Revenues Up 16% To EUR 207.1 Mln

5 Top Gainers In Healthcare Sector (DCPH, MBIO, BCEL...)

CSL FY Profit Rises

Eli Lilly: Taltz Shows Efficacy In Phase 4 Study - Quick Facts

Industries >>

Biotechnology & Drugs News

Securities Lawsuit Filed In Denmark Against Novo Nordisk

Roche: FDA Approved Rozlytrek For Adults With ROS1-positive, Metastatic NSCLC

AstraZeneca: FDA Grants Breakthrough Therapy Designation For Calquence

AstraZeneca Says Lynparza Phase III PAOLA-1 Trial Meets Primary Endpoint

Evotec H1 Group Revenues Up 16% To EUR 207.1 Mln